Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia
2015
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
Interpreting Change Scores of Tests and Measures Used in Physical Therapy
2006 Standout
Determinants of relapse periodicity in Plasmodium vivax malaria
2011
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
2017 Standout
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?
1999
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
2000 Standout
Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
2002
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
1996
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Interpreting the significance of changes in health-related quality-of-life scores.
1998 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
The development of androgen-independent prostate cancer
2001 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Validity of four pain intensity rating scales
2011 Standout
The role of the IL-22/IL-22R1 axis in cancer
2014
Relationship Between Blood Concentrations of Hepcidin and Anemia Severity, Mycobacterial Burden, and Mortality Among Patients With HIV-Associated Tuberculosis
2015
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Malaria
2013 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
DNA Editing by APOBECs: A Genomic Preserver and Transformer
2015
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592
2002
Iron homeostasis and oxidative stress: An intimate relationship
2019
Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument
1997
HIV-1 and interferons: who's interfering with whom?
2015
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
2007 Standout
Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum
2014
A Red Carpet for Iron Metabolism
2017
Extremely High Mutation Rate of HIV-1 In Vivo
2015
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer
2008
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Hidradenitis suppurativa
2020 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
2016 StandoutNobel
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults
2006 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design
2020
Iron Supplementation Benefits Physical Performance in Women of Reproductive Age: A Systematic Review and Meta-Analysis
2014
Back to the future: revisiting HIV-1 lethal mutagenesis
2012
Superinfection in malaria: Plasmodium shows its iron will
2011
NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis
2020
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
2015
Gain‐of‐function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway
2019
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
2005
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain
2003
Coevolution between Mutualists and Parasites in Symbiotic Communities May Lead to the Evolution of Lower Virulence
2017
Control of iron deficiency anemia in low- and middle-income countries
2013
Hormone Resistance in Prostate Cancer
1998
Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
2020
Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.
2002
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
2016 StandoutScience
Iron dysregulation in Huntington's disease
2014
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592
2003
The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block
2017
Hepcidin and the Iron-Infection Axis
2012 Science
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Iron-Deficiency Anemia
2015 Standout
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
Systemic Iron Homeostasis
2013
Regulation of Hepcidin by Erythropoiesis: The Story So Far
2016
The oral microbiota: dynamic communities and host interactions
2018 Standout
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
2003 Standout
Phase III Study of Mitoxantrone Plus Low Dose Prednisone Versus Low Dose Prednisone Alone in Patients With Asymptomatic Hormone Refractory Prostate Cancer
2002
Works of Andrew E. Armitage being referenced
Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study
2014
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.
1994
Host-mediated regulation of superinfection in malaria
2011
APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete “All or Nothing” Phenomenon
2012
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait
2014
Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences
2008
Expression of the Iron Hormone Hepcidin Distinguishes Different Types of Anemia in African Children
2014
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children
2012
Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
2020
Erythroferrone inhibits the induction of hepcidin by BMP6
2018
Hepcidin regulation by innate immune and infectious stimuli
2011
Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children
2014